The new option will be covered by private insurance beginning in January 2027. A major update to federal women’s health preventive guidance will make it easier for women to get screened for cervical ...

A new form of the flu, which is highly contagious and aggressive, is sweeping the nation this season. A mutation of influenza A H3N2, called subclade K, has been detected as the culprit in rising ...

Scientists discovered a small protein region that determines whether plants reject or welcome nitrogen-fixing bacteria. By tweaking only two amino acids, they converted a defensive receptor into one ...

Researchers discovered that a tiny structural feature of the enzyme GPX4 helps keep neurons safe. A rare mutation removes this protection, allowing harmful molecules to damage cell membranes and ...

Hydronuclear experiments, barred globally since the 1990s, may lie behind President Trump’s call last month for the United States to resume its testing of nuclear bombs. By William J. Broad President ...

Top energy and nuclear officials in the Trump administration are planning to meet with the White House and National Security Council in the coming days to dissuade President Donald Trump from resuming ...

Washington — President Trump directed the Pentagon on Wednesday to resume testing of nuclear weapons "on an equal basis" with other countries' tests, possibly ending a decades-long U.S. pause that ...

GYEONGJU, South Korea — President Donald Trump said Wednesday he had instructed the Defense Department to “immediately” start testing nuclear weapons "on an equal basis" with other nations. “Because ...

Oct 30 (Reuters) - U.S. President Donald Trump ordered the U.S. military on Thursday to immediately resume testing nuclear weapons after a gap of 33 years, minutes before beginning a meeting with ...

"Clinicians performing tumor biopsy need to ensure that there’s adequate tissue for both diagnosis and NGS testing. Having immediate pathology review of biopsy specimens in the operating room can ...

NOTCH1 mutations, found in 20% of CLL cases, are associated with poor outcomes in chemotherapy but not yet in treatment guidelines. A retrospective analysis showed improved PFS for NOTCH1-mutated CLL ...

In 2023, Jill Martin took a test that changed her life. She underwent genetic testing for breast cancer and learned she had a BRCA2 mutation, which increases one’s risk of developing breast and other ...